Form 4: Chime Director Sells $4.8M in Class A Stock

Chime Financial Director James Feuille reported the planned sale of 176,168 shares of Class A Common Stock for approximately $4.8 million, executed under a Rule 10b5-1 plan.

Summary

• James Feuille, a Director of Chime Financial, Inc. (CHYM), reported the planned sale of a total of 176,168 shares of Class A Common Stock.
• These transactions are scheduled to occur on December 11, 2025, and are being made pursuant to a Rule 10b5-1 trading plan.
• The first planned sale involves 108,435 shares at a weighted average price of $26.77 per share, with a reported range from $26.40 to $27.34.
• The second planned sale involves 67,733 shares at a weighted average price of $27.69 per share, with a reported range from $27.55 to $27.88.
• The total estimated proceeds from these planned sales are approximately $4.8 million.
• Following these planned transactions, Mr. Feuille's indirect beneficial ownership through various Crosslink entities and trusts will remain substantial, including 7,112,669 shares via Crosslink Crossover Fund VI, L.P. (after the first sale) and 7,044,936 shares (after the second sale), 10,249,701 shares via Crosslink Ventures VII, L.P., 4,392,033 shares via Crosslink Ventures VII-B, L.P., 1,085,859 shares via Crosslink Bayview VII, LLC, 59,780 shares via Crosslink Ventures VII Holdings, LLC, 34,715 shares via one trust, and 12,875 shares via another trust. He also directly owns 7,628 shares.

Sentiment

Score: 4

Explanation: The planned sale of a substantial number of shares by a director, even under a Rule 10b5-1 plan, is typically viewed with slight caution. While 10b5-1 plans mitigate the immediate 'bad news' aspect of insider selling, the underlying decision to sell a significant stake can still suggest that the insider believes the stock is well-valued or that their personal investment strategy warrants a reduction in exposure.

Negatives

• While executed under a Rule 10b5-1 plan, the planned sale of a significant number of shares (176,168 shares for an estimated ~$4.8 million) by a director can still be interpreted by the market as a signal that the insider perceives the stock price to be at a favorable level for liquidation, or that their personal capital allocation strategy dictates a reduction in exposure.

Risks

• Potential for negative market perception due to the planned insider selling, which could put downward pressure on the stock price, even if executed under a pre-arranged plan.
• The sale could signal that the insider believes the stock is fully valued or that future growth may be limited, prompting a reduction in personal holdings.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may interpret the director's planned sale as a signal, potentially influencing their investment decisions and the company's stock price, even though it is pre-scheduled under a 10b5-1 plan.

Key Dates

Recommendation

The planned sale, executed under a Rule 10b5-1 plan, reduces the immediate negative implications typically associated with insider selling, as the decision to sell was made in advance. However, it still represents a director reducing their stake. Investors should 'hold' and observe, recognizing that while the sale is pre-scheduled, it still reflects an insider's decision to divest a portion of their holdings. This warrants continued monitoring of company fundamentals and future insider activity.

Keywords

Chime Financial, CHYM, Insider Sale, Form 4, Director Transaction, Stock Sale, Beneficial Ownership, Equity Disposal, Rule 10b5-1 Plan